AK Medical Holdings Limited disclosed a share repurchase of 100,000 ordinary shares on 29 September 2026 via on-market transactions on the Hong Kong Stock Exchange. The shares were bought at a uniform price of HK$4.83 apiece, translating to a total consideration of HK$0.48 million.

Following the transaction, the company’s issued share capital (excluding treasury shares) declined marginally by 0.0093 % to 1.08 billion shares, while treasury shares increased to 32.82 million. The overall issued share count remained unchanged at 1.11 billion, as repurchased shares are being held in treasury.

The buyback formed part of AK Medical’s existing share repurchase mandate approved on 17 June 2026, which authorises the company to repurchase up to 112.46 million shares. Cumulative repurchases under this mandate now stand at 48.39 million shares, equivalent to 4.30 % of the company’s issued shares at the mandate date.

In line with Hong Kong listing rules, AK Medical is subject to a 30-day moratorium on new share issues or sales of treasury shares following the 29 September transaction, extending through 29 October 2026.